GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Syra Health SYRA · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.80

-0.37%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$7.2m

FY2020FY2025

Net income

−$896,333

FY2020FY2025

Free cash flow

−$447,853

FY2020FY2025

Shareholders' equity

$2.1m

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Revenue$7.2m$8.0m$5.5m$5.6m$1.4m—
Gross profit$2.5m$1.7m$1.4m$1.1m$430,354—
Research and development$67,840$585,146$240,048———
Operating income−$904,324−$3.8m−$2.9m−$2.1m−$3,280−$4,267
Net income−$896,333−$3.8m−$2.9m−$2.1m−$3,280−$4,267
Diluted earnings per share-0.08-0.52-0.46-0.41-0.00-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assets$2.8m$3.7m$4.9m$2.3m$536,889$3,000
Cash and short-term investments$1.6m$2.4m$3.3m$3,344$100,012$3,000
Total liabilities$674,739$800,761$910,072$1.6m$544,036$7,167
Debt$143,787$452,077$248,103$934,839$342,864$3,000
Shareholders' equity$2.1m$2.9m$4.0m$710,098−$7,147−$4,167
Shares outstanding12m7m6m5m1m14m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−$447,746−$2.9m−$2.8m−$2.2m−$88,199—
Capital spending−$107−$11,111−$15,251−$121,260−$6,289—
Free cash flow−$447,853−$2.9m−$2.8m−$2.4m−$94,488—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$2.4m$2.3m$1.7m$1.7m$1.9m$1.9m$2.0m$2.3m
Gross profit$1.1m$971,255$591,170$554,541$752,895$589,156$455,371$668,298
Operating income$251,571$190,983−$135,661−$232,171−$63,158−$473,334−$501,668−$428,910
Net income$250,242$240,979−$134,570−$225,902−$63,596−$472,265−$504,397−$417,535
Diluted earnings per share0.020.02-0.01-0.02-0.01-0.04-0.07-0.06
Cash from operations—$1.0m——————
Total assets$3.8m$3.9m$2.8m$3.3m$3.5m$3.7m$3.7m$4.4m
Cash and short-term investments$2.1m$2.9m$1.6m$2.0m$2.3m$2.5m$2.4m$2.7m
Debt$149,338$73,086$143,787$232,349$108,879$129,807$264,865$349,160
Shareholders' equity$2.6m$2.4m$2.1m$2.2m$2.4m$2.5m$2.9m$3.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.8%——
Operating income-24.4%191.9%—
Net income-24.9%191.4%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin27.2%25.1%——
Operating margin-30.7%-36.6%——
Net margin-30.6%-36.9%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023
Price to earnings-1.1-0.4-0.4
Price to sales0.10.20.2

Share price return

Finished calendar years

202520242023
Return-55%6%-63%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.